Latest News

Potential Lawsuit: Uloric Black Box Warning Legal News and Lawsuit Information

The FDA issued a black box warning for the gout medication Uloric (febuxostat) in February 2019 after results of a clinical safety study found an increased risk of heart-related death and death from all causes compared to other drugs to treat gout. Uloric lawsuits claim that Takeda, the manufacturer of Uloric, failed to warn users of the increased risk of heart attacks and strokes.

Show More

Related Articles